Benaim Ely

CIK 00016322372 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001632237

Recent Transactions

50 trades

Award
NovoCure Ltd$NVCR
Ordinary Shares
2023-01-06$62.30/sh+98→ 28,770 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-08-03$74.00/sh−5,396→ 28,672 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-08-03$71.09/sh−563→ 34,068 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-08-02$69.66/sh−437→ 34,631 total
Award
NovoCure Ltd$NVCR
Ordinary Shares
2022-07-05$59.08/sh+222→ 35,068 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-05-11$61.25/sh−2,135→ 34,846 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-05-10$65.16/sh−2,070→ 36,981 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-03-04$70.41/sh−1,510→ 43,257 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2022-03-03$80.59/sh+30,422→ 30,422 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2022-03-03$80.59/sh+5,452→ 5,452 total
Award
NovoCure Ltd$NVCR
Ordinary Shares
2022-03-03+17,371→ 45,570 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-03-03$74.50/sh−803→ 44,767 total
Award
NovoCure Ltd$NVCR
Ordinary Shares
2022-01-06$63.82/sh+55→ 28,199 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-08-03$150.11/sh−464→ 28,144 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-08-02$149.38/sh−536→ 28,608 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-07-30−651→ 3,253 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-07-30$83.30/sh+651→ 29,795 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-07-30$158.96/sh−651→ 29,144 total
Award
NovoCure Ltd$NVCR
Ordinary Shares
2021-07-06$137.12/sh+90→ 29,144 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-05-27$200.00/sh−1,833→ 29,054 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-05-27−1,833→ 7,332 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-05-27$47.56/sh+1,833→ 30,887 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-05-12$180.48/sh−1,943→ 29,054 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-05-11$180.12/sh−2,262→ 30,997 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-05-10$189.65/sh−1,833→ 33,259 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-05-10$47.56/sh+1,833→ 35,092 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-05-10−1,833→ 9,165 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$200.00/sh−3,474→ 33,259 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$200.00/sh−1,833→ 33,259 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$69.37/sh+3,474→ 36,733 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$47.56/sh+1,833→ 35,092 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$200.00/sh−651→ 33,259 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$83.30/sh+651→ 33,910 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-04-13−1,833→ 10,998 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-04-13−651→ 3,904 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-04-13−3,474→ 19,404 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-03-05$131.53/sh−2,918→ 33,259 total
Sale
NovoCure Ltd$NVCR
Restricted Share Units
2021-03-04$137.55/sh−1,888→ 36,177 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-03-03−3,475→ 22,878 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-03-03$69.37/sh+3,475→ 41,540 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-03-03$150.78/sh−3,475→ 38,065 total
Award
NovoCure Ltd$NVCR
Restricted Share Units
2021-03-02+8,709→ 38,065 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-03-02+16,003→ 16,003 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-12-21$83.30/sh+651→ 30,007 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-12-21$47.56/sh+1,833→ 31,189 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-12-21$156.71/sh−1,833→ 29,356 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-12-21$156.71/sh−651→ 29,356 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-12-21−1,833→ 12,831 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-12-21−651→ 4,555 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-08-03$76.06/sh−660→ 29,356 total

Companies

Recent Filings

Address

C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 455

ROCKVILLE, MD, 20850

View on SEC.gov